LEHI, Utah, Oct. 16, 2025 /PRNewswire/ — Non-profit pharmaceutical company Civica will launch an affordable long-acting insulin – insulin glargine-yfgn in pre-filled pens – at the lowest list price in the current long-acting insulin market. Civica insulin glargine will be available in…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Two of Cytiva’s top executives offer updates on the company’s $1.6 billion in expansion projects worldwide, all to meet growing market demand for its services from developers and manufacturers of advanced therapeutics. The post “In-Region, […]
First-of-its-kind metal-alloy scoring, cutting, and constraining structure (CS) device continues to elevate angioplasty treatment of chronic dialysis fistulas and grafts. PARK CITY, Utah, June 30, 2022 /PRNewswire/ — Transit Scientific shares successful outcomes on multiple […]
LEHI, Utah, Aug. 19, 2022 /PRNewswire/ — SocialClimb, the leading provider of healthcare marketing software that connects physicians with high-value patients, announces it is now offering Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey […]
Copyright © 2026 Biotech Networks
